IRCT20090117001556N108招募中3 期
Tipeptidine as adjuvant therapy in children with ADHD: A double blind and randomised trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 years 至 17 years（—）
- 性别
- All
入选标准
- •Diagnosis of ADHD based on DSM-5
- •Age between 6-17 years old
排除标准
- •Intellectual disability
- •Presence of any psychiatric disorders except for ODD
- •Receiving any neuroleptic during the last 6 months
- •Weight less than 13.5 kg
- •History of allergy to Tipeptidine or Ritaline
- •Presence of any neurologic disease and any condition requiring surgery
- •Uncontrolled seizures
- •Systolic blood pressure more than 125 mm Hg; resting pulse rate less than 60/minute or more than 115/minute
- •Severe medical disease
- •Receiving any medication or supplement for treatment ADHD
研究者
相似试验
已完成
1 期
Tipepidine in children with attention deficit/hyperactivity disorder (AD/HD): a Double-blind, Placebo-controlled TrialAttention deficit/hyperactivity disorder (AD/HD)JPRN-UMIN000015748Department of Psychiatry, Chiba University School of Medicine80
尚未招募
2 期
Treatment for autismCTRI/2023/02/050044Impute inc
进行中（未招募）
不适用
Antiangiogenetic therapy for pediatric patients with inoperable benign tumorsEUCTR2008-006992-57-FIsanna kivivuori
招募中
2 期
Amantadin as adjuvant therapy in the treatment of moderate to severe OCDObsessive-compulsive disorderObsessive- Cumpulsive Disorder.IRCT201705191556N99Tehran University of Medical Sciences50
已完成
不适用
Tipepidine in children with Autism Spectrum Disorder : a 4-week, open-label, preliminary studyAutism Spectrum DisorderJPRN-UMIN000028350Chiba University10